Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.1916
-0.0111 (-5.48%)
At close: Feb 20, 2026, 4:00 PM EST
0.1901
-0.0015 (-0.78%)
After-hours: Feb 20, 2026, 7:50 PM EST
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $3.04 million as of February 20, 2026.
Market Cap
3.04M
Enterprise Value
3.13M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since August 15, 2025, Propanc Biopharma's market cap has decreased from $36.20M to $3.04M, a decrease of -91.61%. That is a compound annual growth rate of -99.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 3.00M | -58.33% |
| Dec 31, 2025 | 7.20M | -80.11% |
| Aug 15, 2025 | 36.20M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.60M |
| Galmed Pharmaceuticals | 3.56M |
| HCW Biologics | 3.33M |
| Dermata Therapeutics | 3.22M |
| Enveric Biosciences | 3.09M |
| Oragenics | 2.94M |
| Adial Pharmaceuticals | 2.72M |
| XORTX Therapeutics | 2.70M |